FDA Clears Dose Control System

Julie Ritzer Ross | | Radiology Business | Business Intelligence
Radiation oncology solutions provider Accuray Inc., Sunnyvale, Calif., today announced that it has obtained 510(k) clearance from the Food and Drug Administration (FDA) to market its Dose Control System (DCS). DCS is a new feature for Accuray’s TomoTherapy® System. It automatically adjusts controls that were previously handled through a manual process, thereby correcting small variations in dose rate and minimizing interruptions. The DCS application is also said to ensure a more stable output over longer duration treatments, such as total marrow and total body Irradiation.Read the press release.

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.